Auxiliary decision-making system for protecting fertility of tumor patient
Through the fertility protection decision-making path module and popular science education module of the auxiliary decision-making system, we help tumor patients make accurate fertility protection decisions, solve the fertility 'zero protection' problem caused by insufficient information in tumor patients, and improve the quality of life and family stability.
Patent Information
- Application Number
- CN202411555750.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-04
- Publication Date
- 2024-12-03
AI Technical Summary
Oncology patients lack accurate and efficient information support when making fertility protection decisions, resulting in a 'zero protection' phenomenon of fertility, affecting quality of life and family stability.
A auxiliary decision-making system was designed, including the patient/caregiver side and the medical staff side. The patient information was entered and analyzed through the fertility protection decision path module, providing fertility protection information and decision-making suggestions, and combining the science popularization education module to provide patients with a full-time period. fertility protection information.
Fast and accurate fertility protection decisions have been achieved, reducing decision-making regrets and family regrets have been achieved, and the quality of life and family stability of tumor patients have been improved.
Smart Images

Figure CN119069117A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of fertility protection, and in particular relates to an auxiliary decision-making system for protecting the fertility of tumor patients. Background Art
[0002] With the development of cancer treatment, the survival rate of cancer patients has been improved, but statistics show that some cancer patients may face the risk of infertility due to cancer treatment. It is of great significance to protect the fertility of cancer patients of childbearing age.
[0003] Since tumors can damage the fertility of cancer patients to a certain extent, cancer patients need to make a decision on whether to protect their fertility before treatment. However, cancer patients usually lack knowledge of medical information and fertility protection, and cannot make correct fertility protection decisions in a short period of time. They may even have "zero protection" of fertility, which leads to regret in the decision and family regret, seriously affecting the quality of life and family stability of cancer patients. Secondly, when making fertility protection decisions, cancer patients rely more on oncology medical staff for information support. However, since oncology medical staff are not fertility experts and have certain limitations in knowledge, the decision support they can provide lacks accuracy and is difficult to provide in a timely and efficient manner. Summary of the invention
[0004] In view of the above-mentioned deficiencies in the prior art, the present invention provides an auxiliary decision-making system for protecting the fertility of cancer patients, which solves the problem of insufficient accuracy and efficiency in assisting cancer patients in making fertility protection decisions.
[0005] In order to achieve the above-mentioned object of the invention, the technical solution adopted by the present invention is:
[0006] The present invention provides an auxiliary decision-making system for protecting the fertility of tumor patients, comprising:
[0007] The patient / caregiver end is used to log in to the independent account of the cancer patient, provide the basic information and treatment intention of the cancer patient to the medical staff through the fertility protection decision-making path module, and view or share the fertility protection information of the cancer patient through the popular science education module;
[0008] The medical end is used to log in to the medical staff account, complete the entry of the basic information and treatment intention information of the cancer patient through the fertility protection decision-making path module, and add, modify or delete the fertility protection information of the cancer patient through the fertility protection decision-making path module;
[0009] The fertility protection decision-making pathway module is used to input the basic information and treatment intention information of cancer patients in a pathway-based manner, analyze the risk of fertility impact on cancer patients, and recommend fertility protection decisions to cancer patients;
[0010] A popular science education module, which is used to provide cancer patients or caregivers with information on fertility protection at all times;
[0011] The decision support module is used to assist in making fertility protection decisions based on the fertility protection information of cancer patients and the recommended fertility protection decisions.
[0012] The beneficial effects of the present invention are as follows: the present invention provides an auxiliary decision-making system for protecting the fertility of cancer patients. By setting a patient / caregiver end to log in to an independent account of the cancer patient and a medical end to log in to the medical staff account, the basic information of the cancer patient and the intention to receive treatment information provided by the cancer patient and / or the caregiver can be efficiently input in a path-based manner in the fertility protection decision-making path module of the system; the fertility protection decision-making path module provided by the present invention can also analyze the fertility impact risk of the cancer patient based on the basic information and the intention to receive treatment information of the cancer patient, and recommend fertility protection decisions to the cancer patient; the present invention provides cancer patients and / or caregivers with fertility protection information of the cancer patient at all times through a popular science education module, so that the cancer patients and caregivers can review the relevant information again at any time and place after receiving the introduction of fertility protection by the medical staff; the present invention uses an auxiliary decision-making module based on the actual situation of the cancer patient and combined with the support of the fertility protection information of the cancer patient, so that the cancer patient can make the best fertility protection decision quickly and accurately on the basis of a comprehensive understanding of the information.
[0013] Furthermore, the fertility protection decision path module includes:
[0014] The first basic information input module is used to input the gender information, age information, disease diagnosis information, disease stage information, marital status information and number of children of the tumor patient in sequence along the path as the basic information of a part of the tumor patient;
[0015] The intention information entry submodule is used to enter the tumor patient's intention to receive treatment along the path;
[0016] The second basic information input submodule is used to input the information of diseases affecting fertility in the past, drugs affecting fertility in the past, and treatments affecting fertility in the past, as the basic information of another part of tumor patients;
[0017] The risk analysis submodule is used to analyze the risk of affecting the fertility of tumor patients based on their basic information and information on their intention to receive treatment, and obtain the risk of affecting the fertility of tumor patients;
[0018] The fertility preservation decision-making submodule is used to recommend fertility preservation decisions to cancer patients based on their basic information and fertility impact risks.
[0019] The beneficial effect of adopting the above further scheme is as follows: the present invention provides a fertility protection decision-making path module, which can realize the rapid and efficient entry of the basic information and intended treatment information of cancer patients in sequence according to the path, and analyze the fertility risk level of cancer patients receiving different therapies under actual circumstances, and provide recommended fertility protection decisions for different fertility risk levels, providing a basis for cancer patients to quickly and accurately make the optimal fertility protection decision after understanding the fertility protection information.
[0020] Furthermore, the intention information entry submodule includes:
[0021] The first intention input unit is used to input the information of the intended surgical method when the tumor patient intends to undergo surgical treatment based on the guidance information of the medical staff;
[0022] The second intention input unit is used to input the information of the chemotherapy drugs to be used when the tumor patient intends to undergo chemotherapy based on the guidance information of the medical staff;
[0023] The third intention input unit is used to input the intended radiotherapy site and dose information of the tumor patient when intending to undergo radiotherapy based on the guidance information of the medical staff;
[0024] The intention to receive treatment entry unit is used to obtain the tumor patient's intention to receive treatment information based on the information on the planned surgical method, the planned chemotherapy drugs, and the planned radiotherapy site and dose.
[0025] The beneficial effect of adopting the above further scheme is: the present invention collects information on the treatment methods that cancer patients intend to adopt by category through the intention information entry sub-module. The treatment methods that cancer patients intend to adopt include any one or any combination of surgery, chemotherapy and radiotherapy. The detailed information of the treatment methods that cancer patients intend to adopt is comprehensively obtained, which helps to accurately analyze the fertility risks of cancer patients and provide a basis for accurately recommending fertility protection decisions to cancer patients.
[0026] Furthermore, the risk analysis submodule includes:
[0027] The gender-age risk analysis unit is used to determine the gender-age risk of the tumor patient according to the gender information and age information of the tumor patient. If the tumor patient is male and older than 45 years old, the gender-age risk is set to be a male high-age risk; if the tumor patient is female and older than 40 years old, the gender-age risk is set to be a female high-age risk;
[0028] A surgical risk analysis unit is used to identify whether the proposed surgical method information includes a high fertility risk surgery. If so, the surgical risk is set to a high surgical risk; otherwise, the surgical risk is set to a low surgical risk;
[0029] The first chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with high fertility risks, and if so, the chemotherapy risk is set to high chemotherapy risk;
[0030] The second chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with medium fertility risk, and if so, the chemotherapy risk is set to medium chemotherapy risk;
[0031] The third chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with low fertility risk, and if so, the chemotherapy risk is set to low chemotherapy risk;
[0032] The first radiotherapy risk analysis unit is used to comprehensively identify the disease diagnosis information of the tumor patient, the planned radiotherapy site and dose information, and obtain the effect of radiation on reproduction, where the effect of radiation on reproduction includes high radiotherapy risk, medium radiotherapy risk and low radiotherapy risk;
[0033] A past disease risk analysis unit is used to determine whether the tumor patient has suffered from a disease that affects fertility in the past based on the information of past diseases that affect fertility, and if so, the risk of having suffered from a disease that affects fertility in the past is set as a high past disease risk;
[0034] A past medication risk analysis unit is used to determine whether the tumor patient has taken drugs that affect fertility in the past, based on the information of drugs that affect fertility in the past. If so, the risk of taking drugs that affect fertility in the past is set as a high past medication risk;
[0035] A past treatment risk analysis unit is used to determine whether the cancer patient has received treatment that affects fertility in the past based on the information of past treatment that affects fertility, and if so, the risk of past treatment that affects fertility is set as a high past treatment risk;
[0036] The high-risk analysis output unit is used to identify whether there is at least one of the following: high-age risk for males, high-age risk for females, high surgical risk, high chemotherapy risk, high radiotherapy risk, high risk of past illness, high risk of past medication, and high risk of past treatment. If so, the risk of fertility impact on the cancer patient is high risk;
[0037] The medium risk analysis output unit is used to identify whether there is at least one of medium chemotherapy risk and medium radiotherapy risk when the risk of affecting fertility of the tumor patient is not high risk. If so, the risk of affecting fertility of the tumor patient is considered medium risk.
[0038] The low-risk analysis output unit is used to determine the risk of affecting fertility of a cancer patient to be low risk when the risk of affecting fertility of the cancer patient is not high risk or medium risk.
[0039] The beneficial effect of adopting the above further scheme is as follows: the present invention provides a risk analysis submodule which analyzes the fertility risks of the tumor patient himself and the fertility risks brought about by the treatment method the tumor patient intends to adopt based on the basic information of the tumor patient and the information on the intended treatment, thereby accurately realizing a comprehensive evaluation of the fertility risks of the tumor patient, and providing a basis for targeted and accurate recommendation of fertility protection decisions for tumor patients with high or medium risk of fertility impact.
[0040] Furthermore, the fertility protection decision submodule includes:
[0041] The risk screening unit is used to select cancer patients with high or medium risk of fertility impact as cancer patients to be recommended;
[0042] The first male cancer patient recommendation unit is used to identify whether the male cancer patient to be recommended is a prepubertal patient, and if so, recommends protecting fertility by participating in clinical trials;
[0043] The second male cancer patient recommendation unit is used to identify whether the male cancer patient to be recommended is post-pubertal, and if so, sperm preservation is recommended to protect fertility;
[0044] The third male cancer patient recommendation unit is used to recommend PD3-5 inhibitors, penile vibration stimulation, electroejaculation or testicular sperm extraction to male cancer patients to protect their fertility after sperm preservation fails;
[0045] The first female cancer patient recommendation unit is used to identify whether the female cancer patients to be recommended are premenarche. If so, whether or not they have received chemotherapy, they are recommended to preserve their fertility through ovarian tissue freezing;
[0046] The second female cancer patient recommendation unit is used to recommend ovarian tissue transplantation to female cancer patients to preserve their fertility when there is no tumor recurrence after ovarian tissue freezing and / or the tumor is a solid tumor;
[0047] The third female cancer patient recommendation unit is used to recommend the female cancer patient to protect her fertility through in vitro maturation and culture technology of immature oocytes when leukemia occurs after ovarian tissue freezing;
[0048] The fourth female cancer patient recommendation unit is used to identify whether the female cancer patient to be recommended is post-menarche, and if so, further determine whether the female cancer patient has received chemotherapy, and if so, recommend ovarian tissue freezing to protect fertility, otherwise the female cancer patient will be regarded as a cancer patient with delayed observation;
[0049] The fifth female cancer patient recommendation unit is used to identify whether a delayed observation cancer patient can delay treatment for two weeks. If so, the female cancer patient is recommended to protect fertility through a combination of ovarian tissue freezing and egg freezing. Otherwise, the female cancer patient is recommended to protect fertility through ovarian tissue freezing.
[0050] The beneficial effect of adopting the above further scheme is: the present invention recommends different fertility protection plans to cancer patients according to the real-time situation of cancer patients and the fertility impact risk level through the fertility protection decision-making sub-module, and provides a basis for cancer patients to make the best fertility protection decision after combining the fertility protection information they have learned.
[0051] Furthermore, the popular science education module is provided with a section for minors and a section for adults; both the section for minors and the section for adults provide information on fertility protection for cancer patients in the form of text materials, comics and videos.
[0052] The beneficial effects of adopting the above further scheme are as follows: the present invention sets up a section for minors and a section for adults in the popular science education module, effectively divides the scale of cancer patients' acceptance of fertility protection information according to age, and fully protects the mental health of cancer patients. The present invention provides fertility protection information for cancer patients in the form of text materials, comics and videos, which is convenient for cancer patients to fully and accurately understand the knowledge related to fertility protection through different forms.
[0053] Furthermore, the fertility protection information for cancer patients includes an introduction to fertility protection knowledge, knowledge on the damage to fertility caused by cancer treatment, an introduction to fertility protection technology and an introduction to sperm bank information.
[0054] The beneficial effect of adopting the above further scheme is: the fertility protection information for cancer patients provided by the present invention, from basic information on fertility protection, fertility damage caused by cancer treatment, fertility protection technology to sperm bank information, is comprehensively and orderly popularized to cancer patients and / or caregivers, so that cancer patients and their caregivers can make the best fertility protection decisions based on the cancer patients' own conditions after scientifically mastering the fertility protection knowledge.
[0055] Other advantages of the present invention will be analyzed in more detail in subsequent embodiments. BRIEF DESCRIPTION OF THE DRAWINGS
[0056] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following briefly introduces the drawings required for use in the embodiments. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.
[0057] Figure 1 The block diagram of an auxiliary decision-making system for protecting fertility of cancer patients in an embodiment of the present invention. DETAILED DESCRIPTION
[0058] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. The components of the embodiments of the present invention generally described and shown in the drawings here can be arranged and designed in various different configurations. Therefore, the following detailed description of the embodiments of the present invention provided in the drawings is not intended to limit the scope of the claimed invention, but merely represents the selected embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without making creative work belong to the scope of protection of the present invention.
[0059] like Figure 1 As shown, in one embodiment of the present invention, the present invention provides an auxiliary decision-making system for protecting fertility of cancer patients, comprising:
[0060] The patient / caregiver end is used to log in to the independent account of the cancer patient, provide the basic information and treatment intention of the cancer patient to the medical staff through the fertility protection decision-making path module, and view or share the fertility protection information of the cancer patient through the popular science education module;
[0061] In this embodiment, the basic information of the cancer patient includes gender information, age information, disease diagnosis information, disease stage information, marital status information, number of children information, past diseases affecting fertility, past medications affecting fertility, and past treatments affecting fertility; the intended treatment information includes information on the planned surgical method, planned chemotherapy drugs, and planned radiotherapy site and dosage.
[0062] The medical end is used to log in to the medical staff account, complete the entry of the basic information and treatment intention information of the cancer patient through the fertility protection decision-making path module, and add, modify or delete the fertility protection information of the cancer patient through the fertility protection decision-making path module;
[0063] In this embodiment, the independent account of the cancer patient can be logged in by the cancer patient himself or his caregiver using a computer, tablet or mobile terminal such as a mobile phone, and the medical staff account can be logged in by the medical staff himself using a computer, tablet or mobile terminal such as a mobile phone, which is convenient and fast.
[0064] In this embodiment, the method of entering the cancer patient fertility protection decision path information can be to check or click the information classification option, or to enter the corresponding information by inputting characters.
[0065] The fertility protection decision-making pathway module is used to input the basic information and treatment intention information of cancer patients in a pathway-based manner, analyze the risk of fertility impact on cancer patients, and recommend fertility protection decisions to cancer patients;
[0066] The fertility protection decision pathway module includes:
[0067] The first basic information input module is used to input the gender information, age information, disease diagnosis information, disease stage information, marital status information and number of children of the tumor patient in sequence along the path as the basic information of a part of the tumor patient;
[0068] In this embodiment, the gender information options of the tumor patient are male or female, and the gender is entered by clicking; the age information of the tumor patient is filled in and entered according to the actual age; the disease diagnosis information and disease stage information of the tumor patient are selected and entered through the drop-down menu; the marital status of the tumor patient includes married, unmarried, widowed and other options, which are checked to confirm the entry; the number of children of the tumor patient is filled in and entered according to the actual number;
[0069] The intention information entry submodule is used to enter the tumor patient's intention to receive treatment along the path;
[0070] In this embodiment, the information on intention to receive treatment includes whether the tumor patient intends to receive surgery, chemotherapy and radiotherapy, as well as the surgical methods, chemotherapy drugs and radiotherapy sites and doses used when receiving surgery, chemotherapy and radiotherapy respectively. The information on intention to receive treatment may include any one or any combination of the three treatment methods, and it is also possible to choose none of the three methods, namely surgery, chemotherapy and radiotherapy, and choose to receive other treatment methods.
[0071] The intention information entry submodule includes:
[0072] The first intention input unit is used to input the information of the intended surgical method when the tumor patient intends to undergo surgical treatment based on the guidance information of the medical staff;
[0073] The second intention input unit is used to input the information of the chemotherapy drugs to be used when the tumor patient intends to undergo chemotherapy based on the guidance information of the medical staff;
[0074] The third intention input unit is used to input the intended radiotherapy site and dose information of the tumor patient when intending to undergo radiotherapy based on the guidance information of the medical staff;
[0075] The intention to receive treatment entry unit is used to obtain the tumor patient's intention to receive treatment information based on the information on the planned surgical method, the planned chemotherapy drugs, and the planned radiotherapy site and dose.
[0076] The second basic information input submodule is used to input the information of diseases affecting fertility in the past, drugs affecting fertility in the past, and treatments affecting fertility in the past, as the basic information of another part of tumor patients;
[0077] In this embodiment, the options for information on past diseases that affect fertility are yes or no, and the information is entered by clicking on it; the options for information on past medications that affect fertility are yes or no, and the information is entered by clicking on it; the options for information on past treatments that affect fertility are yes or no, and the information is entered by clicking on it.
[0078] In this embodiment, factors that may affect the fertility risk of cancer patients are designed in a path-like manner in the form of options, which can avoid medical staff from omitting to inform cancer patients due to insufficient knowledge related to fertility protection, and is particularly beneficial to junior medical staff; the selection and filling form can shorten the time for normal oral notification and discussion, and gain precious time for cancer patients to protect their fertility; in addition, it can also alleviate the discomfort of medical staff and cancer patients discussing fertility protection.
[0079] The risk analysis submodule is used to analyze the risk of affecting the fertility of tumor patients based on their basic information and information on their intention to receive treatment, and obtain the risk of affecting the fertility of tumor patients;
[0080] The risk analysis submodule includes:
[0081] The gender-age risk analysis unit is used to determine the gender-age risk of the tumor patient according to the gender information and age information of the tumor patient. If the tumor patient is male and older than 45 years old, the gender-age risk is set to be a male high-age risk; if the tumor patient is female and older than 40 years old, the gender-age risk is set to be a female high-age risk;
[0082] A surgical risk analysis unit is used to identify whether the proposed surgical method information includes a high fertility risk surgery. If so, the surgical risk is set to a high surgical risk; otherwise, the surgical risk is set to a low surgical risk;
[0083] In this embodiment, high fertility risk surgeries include orchiectomy for testicular cancer, orchiectomy for prostate cancer, radical prostatectomy, cystectomy, retroperitoneal lymph node dissection, and pelvic lymph node dissection.
[0084] The first chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with high fertility risks, and if so, the chemotherapy risk is set to high chemotherapy risk;
[0085] In this embodiment, high fertility risk chemotherapy drugs include cyclophosphamide, procarbazine, melphalan, nitrogen mustard, chloramphenicol, busulfan and other chemotherapy drugs.
[0086] The second chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with medium fertility risk, and if so, the chemotherapy risk is set to medium chemotherapy risk;
[0087] In this embodiment, the intermediate fertility risk chemotherapy drugs include cisplatin, doxorubicin, paclitaxel and other chemotherapy drugs.
[0088] The third chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with low fertility risk, and if so, the chemotherapy risk is set to low chemotherapy risk;
[0089] In this embodiment, the chemotherapy drugs with low fertility risk include methotrexate, vinblastine, 5-fluorouracil, actinomycin D, bleomycin and other chemotherapy drugs.
[0090] The first radiotherapy risk analysis unit is used to comprehensively identify the disease diagnosis information of the tumor patient, the planned radiotherapy site and dose information, and obtain the effect of radiation on reproduction, where the effect of radiation on reproduction includes high radiotherapy risk, medium radiotherapy risk and low radiotherapy risk;
[0091] In this embodiment, when the tumor patient's disease diagnosis information is female cancer, the ovarian irradiation dose will be greater than 2Gy, and the effect of radiation on reproduction is a high radiotherapy risk; when the tumor patient's disease diagnosis information is testicular tubular germ cell tumor, the testicular irradiation dose will be in the range of 16-20Gy, and the effect of radiation on reproduction is a high radiotherapy risk; when the tumor patient's disease diagnosis information is the need for bone marrow or stem cell transplantation, the testicular irradiation dose will be greater than 6Gy, and the effect of radiation on reproduction is a high radiotherapy risk; when the tumor patient's disease diagnosis information is rectal cancer, the testicular irradiation dose will be in the range of 0.3-2.1Gy, and the effect of radiation on reproduction is a medium radiotherapy risk; when the tumor patient's disease diagnosis information is When the diagnosis information of the tumor patient is prostate cancer and intensity-modulated radiotherapy (IMRT) is used, the testicular irradiation dose will be 0.1-0.6Gy, and the effect of radiation on reproduction is a low radiotherapy risk; when the tumor patient's disease diagnosis information is prostate cancer and external radiation therapy (EBRT) is used, the testicular irradiation dose will be 1.8-2.4Gy, and the effect of radiation on reproduction is a low radiotherapy risk; when the tumor patient's disease diagnosis information is seminoma with retroperitoneal lymph node metastasis, the testicular irradiation dose will be 0.3-0.5Gy, and the effect of radiation on reproduction is a low radiotherapy risk; Gy is a dose unit of radiation on biological tissues, which is used to quantify the total amount of radiation given to tumor patients during radiotherapy.
[0092] A past disease risk analysis unit is used to determine whether the tumor patient has suffered from a disease that affects fertility in the past based on the information of past diseases that affect fertility, and if so, the risk of having suffered from a disease that affects fertility in the past is set as a high past disease risk;
[0093] A past medication risk analysis unit is used to determine whether the tumor patient has taken drugs that affect fertility in the past, based on the information of drugs that affect fertility in the past. If so, the risk of taking drugs that affect fertility in the past is set as a high past medication risk;
[0094] A past treatment risk analysis unit is used to determine whether the cancer patient has received treatment that affects fertility in the past based on the information of past treatment that affects fertility, and if so, the risk of past treatment that affects fertility is set as a high past treatment risk;
[0095] The high-risk analysis output unit is used to identify whether there is at least one of the following: high-age risk for males, high-age risk for females, high surgical risk, high chemotherapy risk, high radiotherapy risk, high risk of past illness, high risk of past medication, and high risk of past treatment. If so, the risk of fertility impact on the cancer patient is high risk;
[0096] The medium risk analysis output unit is used to identify whether there is at least one of medium chemotherapy risk and medium radiotherapy risk when the risk of affecting fertility of the tumor patient is not high risk. If so, the risk of affecting fertility of the tumor patient is considered medium risk.
[0097] The low-risk analysis output unit is used to determine the risk of affecting fertility of a cancer patient to be low risk when the risk of affecting fertility of the cancer patient is not high risk or medium risk.
[0098] The fertility preservation decision-making submodule is used to recommend fertility preservation decisions to cancer patients based on their basic information and fertility impact risks.
[0099] The fertility protection decision-making submodule includes:
[0100] The risk screening unit is used to select cancer patients with high or medium risk of fertility impact as cancer patients to be recommended;
[0101] The first male cancer patient recommendation unit is used to identify whether the male cancer patient to be recommended as a cancer patient is a prepubertal patient. If so, it is recommended to protect fertility by participating in clinical trials. In this embodiment, clinical trials refer to patients who can consider participating in some clinical trials for process verification based on the recommendation of medical staff to try to protect fertility.
[0102] The second male cancer patient recommendation unit is used to identify whether the male cancer patient to be recommended is post-pubertal, and if so, sperm preservation is recommended to protect fertility;
[0103] The third male cancer patient recommendation unit is used to recommend PD3-5 inhibitors, penile vibration stimulation, electroejaculation or testicular sperm extraction to male cancer patients to protect their fertility after sperm preservation fails;
[0104] The first female cancer patient recommendation unit is used to identify whether the female cancer patients to be recommended are premenarche. If so, whether or not they have received chemotherapy, they are recommended to preserve their fertility through ovarian tissue freezing;
[0105] The second female cancer patient recommendation unit is used to recommend ovarian tissue transplantation to female cancer patients to preserve their fertility when there is no tumor recurrence after ovarian tissue freezing and / or the tumor is a solid tumor;
[0106] The third female cancer patient recommendation unit is used to recommend the female cancer patient to protect her fertility through in vitro maturation and culture technology of immature oocytes when leukemia occurs after ovarian tissue freezing;
[0107] The fourth female cancer patient recommendation unit is used to identify whether the female cancer patient to be recommended is post-menarche, and if so, further determine whether the female cancer patient has received chemotherapy, and if so, recommend ovarian tissue freezing to protect fertility, otherwise the female cancer patient will be regarded as a cancer patient with delayed observation;
[0108] The fifth female cancer patient recommendation unit is used to identify whether a delayed observation cancer patient can delay treatment for two weeks. If so, the female cancer patient is recommended to protect fertility through a combination of ovarian tissue freezing and egg freezing. Otherwise, the female cancer patient is recommended to protect fertility through ovarian tissue freezing.
[0109] A popular science education module, which is used to provide cancer patients or caregivers with information on fertility protection at all times;
[0110] The popular science education module is provided with a section for minors and a section for adults; both the section for minors and the section for adults provide information on fertility protection for cancer patients in the form of text materials, comics and videos.
[0111] The fertility protection information for cancer patients includes an introduction to fertility protection knowledge, knowledge on the damage to fertility caused by cancer treatment, an introduction to fertility protection technology and an introduction to sperm bank information.
[0112] In this embodiment, cancer patients and caregivers can log in to the system to view fertility risk assessment results and fertility protection related popular science education knowledge in different occasions, thereby helping cancer patients and their families to repeatedly study relevant information and jointly make the final decision on fertility protection. In addition, the sharing setting of popular science education content can also realize the dissemination of fertility protection popular science content and realize knowledge sharing.
[0113] The decision support module is used to assist in making fertility protection decisions based on the fertility protection information of cancer patients and the recommended fertility protection decisions.
[0114] By providing recommendations for cancer patients, the present invention greatly reduces the time for medical staff to be informed, for doctor-patient discussions, and for patients to make decisions, effectively avoiding delays in cancer treatment, ensuring clinical treatment effects, and increasing patients' long-term life and quality of life. The present invention can fully obtain information related to fertility protection, and make the best fertility protection decision based on the recommendations of the system, which can effectively reduce negative emotions such as decision regret.
[0115] The above description is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. An auxiliary decision-making system for protecting fertility of cancer patients, characterized in that: include: The patient / caregiver end is used to log in to the independent account of the cancer patient, provide the basic information and treatment intention of the cancer patient to the medical staff through the fertility protection decision-making path module, and view or share the fertility protection information of the cancer patient through the popular science education module; The medical end is used to log in to the medical staff account, complete the entry of the basic information and treatment intention information of the cancer patient through the fertility protection decision-making path module, and add, modify or delete the fertility protection information of the cancer patient through the fertility protection decision-making path module; The fertility protection decision-making pathway module is used to input the basic information and treatment intention information of cancer patients in a pathway-based manner, analyze the risk of fertility impact on cancer patients, and recommend fertility protection decisions to cancer patients; A popular science education module, which is used to provide cancer patients or caregivers with information on fertility protection at all times; The decision support module is used to assist in making fertility protection decisions based on the fertility protection information of cancer patients and the recommended fertility protection decisions.
2. The auxiliary decision-making system for protecting fertility of cancer patients according to claim 1, characterized in that: The fertility protection decision pathway module includes: The first basic information input module is used to input the gender information, age information, disease diagnosis information, disease stage information, marital status information and number of children of the tumor patient in sequence along the path as the basic information of a part of the tumor patient; The intention information entry submodule is used to enter the tumor patient's intention to receive treatment along the path; The second basic information input submodule is used to input the information of diseases affecting fertility in the past, drugs affecting fertility in the past, and treatments affecting fertility in the past, as the basic information of another part of tumor patients; The risk analysis submodule is used to analyze the risk of affecting the fertility of tumor patients based on their basic information and information on their intention to receive treatment, and obtain the risk of affecting the fertility of tumor patients; The fertility preservation decision-making submodule is used to recommend fertility preservation decisions to cancer patients based on their basic information and fertility impact risks.
3. The auxiliary decision-making system for protecting fertility of cancer patients according to claim 2, characterized in that: The intention information entry submodule includes: The first intention input unit is used to input the information of the intended surgical method when the tumor patient intends to undergo surgical treatment based on the guidance information of the medical staff; The second intention input unit is used to input the information of the chemotherapy drugs to be used when the tumor patient intends to undergo chemotherapy based on the guidance information of the medical staff; The third intention input unit is used to input the intended radiotherapy site and dose information of the tumor patient when intending to undergo radiotherapy based on the guidance information of the medical staff; The intention to receive treatment entry unit is used to obtain the tumor patient's intention to receive treatment information based on the information on the planned surgical method, the planned chemotherapy drugs, and the planned radiotherapy site and dose.
4. The auxiliary decision-making system for protecting fertility of cancer patients according to claim 3, characterized in that: The risk analysis submodule includes: The gender-age risk analysis unit is used to determine the gender-age risk of the tumor patient according to the gender information and age information of the tumor patient. If the tumor patient is male and older than 45 years old, the gender-age risk is set to be a male high-age risk; if the tumor patient is female and older than 40 years old, the gender-age risk is set to be a female high-age risk; A surgical risk analysis unit is used to identify whether the proposed surgical method information includes a high fertility risk surgery. If so, the surgical risk is set to a high surgical risk; otherwise, the surgical risk is set to a low surgical risk; The first chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with high fertility risks, and if so, the chemotherapy risk is set to high chemotherapy risk; The second chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with medium fertility risk, and if so, the chemotherapy risk is set to medium chemotherapy risk; The third chemotherapy risk analysis unit is used to identify whether the proposed chemotherapy drug information contains chemotherapy drugs with low fertility risk, and if so, the chemotherapy risk is set to low chemotherapy risk; The first radiotherapy risk analysis unit is used to comprehensively identify the disease diagnosis information of the tumor patient, the planned radiotherapy site and dose information, and obtain the effect of radiation on reproduction, where the effect of radiation on reproduction includes high radiotherapy risk, medium radiotherapy risk and low radiotherapy risk; A past disease risk analysis unit is used to determine whether the tumor patient has suffered from a disease that affects fertility in the past based on the information of past diseases that affect fertility, and if so, the risk of having suffered from a disease that affects fertility in the past is set as a high past disease risk; A past medication risk analysis unit is used to determine whether the tumor patient has taken drugs that affect fertility in the past, based on the information of drugs that affect fertility in the past. If so, the risk of taking drugs that affect fertility in the past is set as a high past medication risk; A past treatment risk analysis unit is used to determine whether the cancer patient has received treatment that affects fertility in the past based on the information of past treatment that affects fertility, and if so, the risk of past treatment that affects fertility is set as a high past treatment risk; The high-risk analysis output unit is used to identify whether there is at least one of the following: high-age risk for males, high-age risk for females, high surgical risk, high chemotherapy risk, high radiotherapy risk, high risk of past illness, high risk of past medication, and high risk of past treatment. If so, the risk of fertility impact on the cancer patient is high risk; The medium risk analysis output unit is used to identify whether there is at least one of medium chemotherapy risk and medium radiotherapy risk when the risk of affecting fertility of the tumor patient is not high risk. If so, the risk of affecting fertility of the tumor patient is considered medium risk. The low-risk analysis output unit is used to determine the risk of affecting fertility of a cancer patient to be low risk when the risk of affecting fertility of the cancer patient is not high risk or medium risk.
5. The auxiliary decision-making system for protecting fertility of cancer patients according to claim 4, characterized in that: The fertility protection decision-making submodule includes: The risk screening unit is used to select cancer patients with high or medium risk of fertility impact as cancer patients to be recommended; The first male cancer patient recommendation unit is used to identify whether the male cancer patient to be recommended is a prepubertal patient, and if so, recommends protecting fertility by participating in clinical trials; The second male cancer patient recommendation unit is used to identify whether the male cancer patient to be recommended is post-pubertal, and if so, sperm preservation is recommended to protect fertility; The third male cancer patient recommendation unit is used to recommend PD3-5 inhibitors, penile vibration stimulation, electroejaculation or testicular sperm extraction to male cancer patients to protect their fertility after sperm preservation fails; The first female cancer patient recommendation unit is used to identify whether the female cancer patients to be recommended are premenarche. If so, whether or not they have received chemotherapy, they are recommended to preserve their fertility through ovarian tissue freezing; The second female cancer patient recommendation unit is used to recommend ovarian tissue transplantation to female cancer patients to preserve their fertility when there is no tumor recurrence after ovarian tissue freezing and / or the tumor is a solid tumor; The third female cancer patient recommendation unit is used to recommend the female cancer patient to protect her fertility through in vitro maturation and culture technology of immature oocytes when leukemia occurs after ovarian tissue freezing; The fourth female cancer patient recommendation unit is used to identify whether the female cancer patient to be recommended is post-menarche, and if so, further determine whether the female cancer patient has received chemotherapy, and if so, recommend ovarian tissue freezing to protect fertility, otherwise the female cancer patient will be regarded as a cancer patient with delayed observation; The fifth female cancer patient recommendation unit is used to identify whether a delayed observation cancer patient can delay treatment for two weeks. If so, the female cancer patient is recommended to protect fertility through a combination of ovarian tissue freezing and egg freezing. Otherwise, the female cancer patient is recommended to protect fertility through ovarian tissue freezing.
6. The auxiliary decision-making system for protecting fertility of cancer patients according to claim 1, characterized in that: The popular science education module is provided with a section for minors and a section for adults; both the section for minors and the section for adults provide information on fertility protection for cancer patients in the form of text materials, comics and videos.
7. The auxiliary decision-making system for protecting fertility of cancer patients according to claim 6, characterized in that: The fertility protection information for cancer patients includes an introduction to fertility protection knowledge, knowledge on the damage to fertility caused by cancer treatment, an introduction to fertility protection technology and an introduction to sperm bank information.
Citation Information
Patent Citations
Reinforcement learning based tumor treatment auxiliary decision-making method
CN113270189A
Systems and methods for providing fertility enhanced diet recommendations in individuals with low testosterone
CN115398561A
Children remote medical decision-making system
CN116779134A
Intelligent wearable health monitoring and nursing auxiliary equipment for radiotherapy patient
CN118766429A
Design Method of Oncological Computerized Physician Order Entry System with Intelligent Clinical Decision Recommendation Function
US20230031792A1
